U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Perry Drugs Inc. - 11/18/2016
  1. Warning Letters


Perry Drugs Inc.

Perry Drugs Inc.

United States

Issuing Office:

United States



Black HHS-Blue FDA Logo



Kansas City District
8050 Marshall Drive, Suite 205
Lenexa, KS 66214
Telephone: (913) 495-5100
FAX: (913) 495-5115 

November 18, 2016

Dena K. Perry, President
Perry Drug, Inc.
12200 W 106th St. Ste 140
Overland Park, KS 66215-2305

Dear Ms. Perry:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our warning letter dated February 3, 2015. We acknowledge that your firm no longer produces sterile drug products. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.

You are expected to take all necessary steps to assure compliance with the Federal Food, Drug, and Cosmetic Act and FDA's implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Cheryl A. Bigham
Kansas City District Dire

Back to Top